Pharmaceutical Care of Hypertension Induced by the Combination of Cyclosporine A and Voriconazole in A Child with Aplastic Anemia
10.3870/j.issn.1004-0781.2017.12.022
- VernacularTitle:环孢素联用伏立康唑致再生障碍性贫血患儿血压持续升高的药学监护
- Author:
Jindong WU
1
;
jinchun QIU
;
Yong ZHANG
Author Information
1. 佛山市三水区妇幼保健院
- Keywords:
Cyclosporin A;
Voriconazole;
Interactions;
drug;
Hypertension
- From:
Herald of Medicine
2017;36(12):1419-1421
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the pharmacy practice of clinical pharmacists' attendance in the treatment of adverse reactions caused by drug interactions. Methods Analysis was conducted on the causes and treatment of hypertension in one pedinatric patient with aplastic anemia induced by combined use of cyclosporine and voriconazole. Results Cyclosporine A could lead to prolonged hypertension.Cyclosporine A dosage should be adjusted;antihypertensive drugs should be used in necessity.When choosing antihypertensive drugs,drug interaction with cyclosporine A should be considered. Conclusion Clinical pharmacists could manage adverse drug reactions by analyzing drug interactions,and offer suggestions for ADR patients.
